• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    One in Three Cigarettes in the Region of The Americas in 2025 Is Illicit, New Study Finds

    4/15/26 8:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $PM alert in real time by email
    • A new report highlights that 31.9% of cigarettes consumed in the Latin America and Canada region are from the illicit market, making it a global hotspot for illicit cigarette consumption, according to Philip Morris International internal estimates and other third-party reports.
    • An estimated 77 billion illicit cigarettes were consumed in 2025 across the 11 countries analyzed in the study, resulting in an estimated USD 8.5 billion in lost tax revenues during the year.

    Philip Morris International (NYSE:PM) today emphasizes the importance of effective policymaking in responding to the growing illicit tobacco trade in the Region of the Americas (excluding the United States), where almost one out of every three cigarettes consumed across 11 countries in the region comes from illegal sources.

    The results of the study, conducted by KPMG LLP on behalf of Philip Morris Products S.A., reflect that illicit trade is a defining feature of the regional cigarette market. In 2025, an estimated 77 billion illicit cigarettes were consumed across the region, representing 31.9% of total cigarette consumption. The scale of illicit trade highlights the growth of an unregulated parallel economy: the Region of the Americas (excluding the U.S.) has the highest rate of illicit cigarette consumption worldwide, with an incidence more than twice the global average of 15%, according to PMI internal estimates based on industry reports and third-party research studies.

    "Reports like this are relevant not only to highlight the illicit cigarette trade problem, but also to invite authorities to search for solutions, which promote technological innovation, intelligence gathering, and data-driven action," said Marco Hannappel, President, Latin America & Canada. "Philip Morris International believes partnering with governments can help tackle this problem, and that balanced regulations allowing commercialization of new smoke-free products can end smoking, which would in turn indirectly decrease illicit cigarette trade," he added.

    Illicit consumption remains resilient and structurally high across the region, showing that extreme regulations and steep and abrupt tax increases can boost the illicit tobacco trade.

    While some governments across the region have imposed heavier taxes and regulations on tobacco products, the current state of illicit trade in the region shows that demand for cheaper products is not disappearing. Instead, it is shifting toward illegal markets, where consumers can find a wide array of illicit cigarettes.

    The implications extend beyond the tobacco sector, as the report estimates that illicit cigarette consumption resulted in an estimated USD 8.5 billion in lost tax revenues across the region in 2025.

    "These are resources that could otherwise fund public goods such as healthcare, education, infrastructure, and enforcement capacity. Instead, they are captured by an illicit market," said Hannappel.

    Illicit trade is not only a fiscal issue – it is also a public health, security, and institutional challenge. Illegal products bypass controls, expose consumers to unknown risks, and weaken the effectiveness of regulation.

    In several countries, illicit trade has reached levels that displace the legal market. Brazil remains the largest illicit cigarette market in the surveyed region by volume and fiscal impact, while in countries such as Panama and Ecuador illicit products account for more than 80% of consumption, illustrating how illicit trade expands when enforcement, regulation, and market conditions fall out of alignment.

    Philip Morris Products S.A. commissioned KPMG LLP to develop the analysis to contribute data-driven evidence to policymakers, stakeholders, and enforcement authorities across 11 markets in the Region of the Americas, with the aim of supporting more informed public discussion and more effective policy and enforcement responses.

    The 11 countries studied for this analysis are Argentina, Brazil, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico and Panama.

    The report was presented at an event hosted by the Council of the Americas (COA) in Washington, D.C., where experts from government, academia, and the private sector discussed the scale of the challenge and the need for coordinated responses.

    Key Report Findings:

    1. Almost a third of cigarettes consumed in Latin America and Canada are illicit. In 2025 31.9% of all cigarettes consumed in the region were illicit.
    2. A total of 77 billion illicit cigarettes were consumed in 2025 in the 11 countries included in the report across Latin America and Canada. Public enforcement reporting consistently links illicit cigarettes to wider criminal economies, including other contraband and illicit activities.
    3. Illicit trade is draining public finances at scale. An estimated USD 8.5 billion in tax revenues was lost in 2025 due to illicit cigarette consumption.
    4. Illicit trade proved more resilient than the legal market. Illicit cigarette use declined much less than total cigarette consumption in 2025.
    5. Brazil is the largest illicit cigarette market in the region. In 2025, it accounted for 41.8 billion illicit cigarettes, representing 54% of total illicit consumption across the 11 markets.
    6. Panama and Ecuador have reached critical levels of illicit consumption. Illicit cigarettes account for approximately 89% of total consumption in Panama and 84% in Ecuador.
    7. Illicit Whites (cigarettes that are in most cases legally produced in a country, but with the sole intention of being smuggled into other markets) dominate the illegal market. They represent 73% of all illicit cigarettes, equivalent to approximately 56.5 billion cigarettes.

    A detailed overview of the results, country profiles and methodology of the study is available here.

    For more information about PMI's illicit trade prevention efforts, visit PMI.com.

    Note to editors

    Definitions of illicit cigarette categories, as detailed in the KPMG report:

    • Counterfeit: "Cigarettes that are illegally manufactured and sold by a party other than the original trademark owner."
    • Illicit whites: "Cigarettes that are usually manufactured legally in one country/market but which the evidence suggests have been smuggled across-borders during their transit to the destination market under review where they have limited or no legal distribution and are sold without payment of tax."
    • C&C: "Counterfeit and contraband, including illicit whites. Contraband refers to genuine products that have been either bought in a lower-tax country and which exceed legal border limits or acquired without taxes for export purposes to be illegally re-sold (for financial profit) in a higher priced market."
    • Other C&C: "Other C&C comprises contraband which does not fall within the Illicit Whites definition. It is often duty paid product. There may also be counterfeit of brands that are not trademark-owned by participant manufacturers."

    Philip Morris International: A Global Smoke-Free Champion

    Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025, PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 41.5% of PMI's full year 2025 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match's General snus and ZYN nicotine pouches and versions of PMI's IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness areas. References to "PMI", "we", "our" and "us" mean Philip Morris International Inc., and its subsidiaries. For more information, please visit www.pmi.com and www.pmiscience.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260415853733/en/

    Philip Morris International

    Corey Henry

    T. +1 (202) 679 7296

    E. [email protected]

    Get the next $PM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PM

    DatePrice TargetRatingAnalyst
    1/20/2026$180.00Buy → Hold
    Jefferies
    7/9/2025$220.00Buy
    Jefferies
    5/22/2025$195.00Buy
    Needham
    4/25/2025$170.00Sell → Neutral
    UBS
    3/14/2025Hold → Buy
    Argus
    1/16/2025$140.00Overweight
    Morgan Stanley
    3/5/2024Buy → Hold
    Argus
    2/13/2024Sell → Hold
    Societe Generale
    More analyst ratings

    $PM
    SEC Filings

    View All

    SEC Form DEFA14A filed by Philip Morris International Inc

    DEFA14A - Philip Morris International Inc. (0001413329) (Filer)

    3/31/26 2:03:06 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Philip Morris International Inc

    SCHEDULE 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    3/27/26 11:22:44 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEFA14A filed by Philip Morris International Inc

    DEFA14A - Philip Morris International Inc. (0001413329) (Filer)

    3/26/26 6:06:32 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    One in Three Cigarettes in the Region of The Americas in 2025 Is Illicit, New Study Finds

    A new report highlights that 31.9% of cigarettes consumed in the Latin America and Canada region are from the illicit market, making it a global hotspot for illicit cigarette consumption, according to Philip Morris International internal estimates and other third-party reports. An estimated 77 billion illicit cigarettes were consumed in 2025 across the 11 countries analyzed in the study, resulting in an estimated USD 8.5 billion in lost tax revenues during the year. Philip Morris International (NYSE:PM) today emphasizes the importance of effective policymaking in responding to the growing illicit tobacco trade in the Region of the Americas (excluding the United States), where almost

    4/15/26 8:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International to Host Webcast of 2026 First-Quarter Results

    Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) will host a live audio webcast on Wednesday, April 22, 2026, at 9:00 a.m. ET, to discuss its 2026 First-Quarter financial results, which will be issued at approximately 7:00 a.m. ET the same day. The webcast can be accessed here. The webcast will be hosted by Emmanuel Babeau, Group Chief Financial Officer, and will include discussion of PMI's financial results and a Q&A session with the investment community. The webcast will be in a listen-only mode. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at www.pmi.com/irapp. The webcast recording and the slides and script will

    4/15/26 7:59:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    New "Forgotten Smoker" White Paper from PMI U.S. Warns That America Didn't End Smoking; It Just Moved On--and 8 in 10 Americans Surveyed Demand a Better Approach

    The paper calls for immediate steps to make cigarette smoking a public health priority in the U.S. and to better understand adult smokers, who feel judged, ignored, and left behindWASHINGTON, April 14, 2026 /PRNewswire/ -- America likes to believe it has solved the problem of smoking. It hasn't. Results of a new national survey, released today, show that 79% of Americans say more must be done to combat smoking-related harm. Philip Morris International's U.S. business (PMI U.S.) agrees, as detailed in The Forgotten Smoker: Modern Solutions to America's Oldest Public Health Challenge. This white paper makes the case for policymakers, public health authorities, and medical professionals to rece

    4/14/26 8:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Philip Morris International downgraded by Jefferies with a new price target

    Jefferies downgraded Philip Morris International from Buy to Hold and set a new price target of $180.00

    1/20/26 9:10:49 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Jefferies resumed coverage on Philip Morris International with a new price target

    Jefferies resumed coverage of Philip Morris International with a rating of Buy and set a new price target of $220.00

    7/9/25 8:31:10 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Needham initiated coverage on Philip Morris International with a new price target

    Needham initiated coverage of Philip Morris International with a rating of Buy and set a new price target of $195.00

    5/22/25 8:27:06 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Group Controller Dobrowolski Reginaldo covered exercise/tax liability with 22 shares (SEC Form 4)

    4 - Philip Morris International Inc. (0001413329) (Issuer)

    3/9/26 4:23:03 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Group Chief Financial Officer Babeau Emmanuel covered exercise/tax liability with 2,228 shares and sold $6,138,418 worth of shares (33,800 units at $181.61), decreasing direct ownership by 18% to 164,463 units (SEC Form 4)

    4 - Philip Morris International Inc. (0001413329) (Issuer)

    2/20/26 4:01:45 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Group Controller Dobrowolski Reginaldo covered exercise/tax liability with 250 shares and sold $1,100,880 worth of shares (6,000 units at $183.48), decreasing direct ownership by 20% to 21,182 units (SEC Form 4)

    4 - Philip Morris International Inc. (0001413329) (Issuer)

    2/20/26 4:01:38 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

    SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    2/9/24 6:21:26 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

    SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    2/9/24 6:05:54 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Philip Morris International Inc (Amendment)

    SC 13G/A - Philip Morris International Inc. (0001413329) (Subject)

    1/29/24 3:26:29 PM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Financials

    Live finance-specific insights

    View All

    Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share

    Regulatory News: The Board of Directors of Philip Morris International Inc. (NYSE:PM) today declared a regular quarterly dividend of $1.47 per common share, payable on April 13, 2026, to shareholders of record as of March 19, 2026. The ex-dividend date is March 19, 2026. For more details on stock, dividends and other information, see www.pmi.com/dividend. Philip Morris International: A Global Smoke-Free Champion Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company's current product portfolio primarily

    3/5/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Presents at 2026 CAGNY Conference; Reaffirms 2026 Full-Year Forecast

    Regulatory News: Philip Morris International Inc.'s (PMI) (NYSE:PM) Group CEO PMI, Jacek Olczak, and Group Chief Financial Officer, Emmanuel Babeau, will address investors today at the 2026 Consumer Analyst Group of New York (CAGNY) Conference at approximately 10:00 a.m. ET. The live webcast and presentation slides will be available here. The webcast replay will be available at the same link for six months after the event. The webcast may also be accessed on mobile devices by downloading PMI's Investor Relations App at www.pmi.com/irapp. The presentation will cover: How a transformed PMI is leading the industry in an evolving operating environment; The success and future opportu

    2/18/26 7:00:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Reports 2025 Fourth-Quarter & Full-Year Results

    Delivers Full Year 2025 Reported Diluted EPS of $7.26 compared to $4.52 in 2024 and Adjusted Diluted EPS of $7.54, Representing Growth of 14.8%, and 14.2% on a Currency-Neutral Basis; Provides 2026 - 2028 Growth Targets Regulatory News: Philip Morris International Inc. (PMI) (NYSE:PM) today announces its 2025 fourth quarter results.1 "We achieved another remarkable year of results in 2025, with a fifth consecutive year of volume growth, net revenues surpassing $40 billion, including close to $17 billion from our smoke-free business, and very good operating margin expansion," said Jacek Olczak, Group CEO PMI. "With excellent results in 2024 and 2025, we have delivered our three-year CA

    2/6/26 6:59:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    $PM
    Leadership Updates

    Live Leadership Updates

    View All

    Philip Morris International Opens Dialogue on the Future of Human Cognition as a Defining Frontier in the Age of AI

    The paper calls for global debate to ensure AI enhances—rather than diminishes—uniquely human strengths in an increasingly automated world Philip Morris International Inc. (NYSE:PM) today released a new white paper, "Human Cognition: The Next Frontier?", inviting leaders across business, policy, and academia to join a global conversation on the evolving role of human cognition as artificial intelligence transforms work, society, and the economy. The white paper explores how human capabilities such as - critical thinking, creativity and adaptability - are poised to become the "superskill" of the future, driving progress in an era of human-machine collaboration. As AI automates routine ta

    1/20/26 5:03:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

    Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services of Vectura and Phillips Medisize Phillips Medisize to add a market-leading position in inhalation combination product development to its existing suite of drug delivery device design capabilities Vectura employees to join a large global company, dedicated to improving patients' lives through innovative products and world class quality and manufacturing capabilities Molex, a parent to Phillips Medisize, a leader in the design, engineering and manufacturing of pharmaceutical drug delivery, in vitro diagnostic and medtech devices, announced that, through its affiliate Molex

    9/17/24 9:11:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care

    Philip Morris International Names New External Affairs Leader

    Philip Morris International Inc. (PMI) (NYSE:PM) is pleased to announce the appointment of Christos Harpantidis to the position of Senior Vice President, External Affairs effective May 1, 2024. In his new role, Mr. Harpantidis will report to the company's CEO, Jacek Olczak. "Christos is an experienced business leader with a proven track record of engaging society on the benefits of tobacco harm reduction and risk-proportionate regulation for smoke-free products," said CEO Jacek Olczak. "He has been instrumental in building our smoke-free business in Greece and the South East Europe Area as we evolve away from cigarettes. I'm looking forward to working with Christos and excited to see what

    3/26/24 5:48:00 AM ET
    $PM
    Medicinal Chemicals and Botanical Products
    Health Care